Healthcare and Economic Governance Challenges

This chapter analyzes UnitedHealth Group's struggles against competitors and explores Eli Lilly's breakthrough in weight loss treatments, impacting pharmaceutical stocks. It delves into concerns regarding the Federal Reserve's independence amidst political pressures, emphasizing the need for stability in economic governance. The discussion encompasses the implications of presidential powers over tariff policies and their effects on market competition, advocating for transparency and accountability in trade practices.